• Full Text
  • Scholarly Journal

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model

; Basel Vol. 13, Iss. 3,  (2021): 487.
DOI:10.3390/cancers13030487